中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Rescue of Infants With MCT8 Deficiency

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态
赞助商
Roy E. Weiss, M.D.

关键词

抽象

MCT8 deficiency (that is also known as Allan-Herndon-Dudley syndrome) is a rare X-linked inherited disorder of brain development that causes severe intellectual disability and problems with movement.

描述

MCT8 deficiency (that is also known as Allan-Herndon-Dudley syndrome) is a rare X-linked inherited disorder of brain development that causes severe intellectual disability and problems with movement. This condition, which occurs almost exclusively in males, disrupts development from before birth. There is no sucking reflex and the child has marked hypotonia. Developmentally, unlike normal infants, affected males are unable to turn over from belly to back. Individuals with identical mutations have identical phenotypes and all individuals, regardless of the phenotype have severe neuropsychological impairment. Diagnosis is confirmed by demonstration of a mutation in the MCT8 gene (1,2).

MCT8-specific thyroid hormone cell-membrane transporter deficiency is characterized by severe cognitive deficiency, infantile hypotonia, diminished muscle mass and generalized muscle weakness, progressive spastic quadriplegia, joint contractures, and dystonic and/or athetoid movement with characteristic paroxysms or kinesigenic dyskinesias. Seizures occur in about 25% of cases. Most affected males never sit or walk independently or lose these abilities over time; most never speak or have severely dysarthric speech (1). Brain MRI obtained in the first few years of life shows transient delayed myelination, which improves by age four years (3). Although psychomotor findings observed in affected males do not occur in heterozygous females, the latter often have thyroid test abnormalities intermediate between affected and normal individuals.

日期

最后验证: 05/31/2020
首次提交: 04/23/2018
提交的预估入学人数: 10/27/2019
首次发布: 10/28/2019
上次提交的更新: 06/02/2020
最近更新发布: 06/04/2020

状况或疾病

Mct8 (Slc16A2)-Specific Thyroid Hormone Cell Transporter Deficiency

干预/治疗

Drug: Diiodothyropropionic acid

-

资格标准

有资格学习的性别Male
接受健康志愿者没有
标准

Inclusion Criteria:

- After confirmation of MCT8 gene mutation of the male fetus

- A child or children previously born with severe, typical phenotype and MCT8 gene mutation identical to that of the fetus to be treated in the mother or a sister who has a relative with known MCT8 defect

- Parental refusal to terminate the pregnancy

Exclusion Criteria:

- Twin Pregnancy

- Election to terminate pregnancy

- Maternal hyperthyroidism requiring treatment

- Patient with significant liver or kidney insufficiency

- Congestive heart failure

- Hyperemesis unresponsive to treatment

- Significant maternal cardiac-related conditions (atrial fibrillation, other arrhythmia's, unstable angina coronary heart disease

- sympathomimetic therapy

- Anticoagulant therapy

- Patients taking Cytochrome P450 2C9 (CYP2C9) inhibitors with narrow therapeutic index

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge